Does AZD-1222 Cause Decreased appetite? 59 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Decreased appetite have been filed in association with AZD-1222. This represents 2.5% of all adverse event reports for AZD-1222.
59
Reports of Decreased appetite with AZD-1222
2.5%
of all AZD-1222 reports
0
Deaths
24
Hospitalizations
How Dangerous Is Decreased appetite From AZD-1222?
Of the 59 reports, 24 (40.7%) required hospitalization, and 2 (3.4%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which AZD-1222 Alternatives Have Lower Decreased appetite Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT